Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.36 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28518589 | 1.00 | RARB (0.39) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL8559662 | 1.00 | RARB (0.39) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL28282898 | 1.00 | RARB (0.39) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL11679430 | 0.98 | RARB (0.40) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL26131903 | 0.91 | BLM (0.38) | RARBLMNABLMALDH1A1ACHE | |
| SCHEMBL29220171 | 0.84 | TSHR (0.39) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL10529481 | 0.83 | TSHR (0.44) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL1940168 | 0.83 | RARB (0.41) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL9954635 | 0.83 | TSHR (0.44) | RARBNAAAKDM4CKDM4APHF8 | |
| SCHEMBL6269256 | 0.83 | RARB (0.41) | RARBNAAAKDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3666755-A1 | ONLINE FULL CONTINUOUS FLOW PRODUCTION PROCESS FOR DIRECTLY PREPARING ORGANIC PEROXIDE WITH HYDROGEN PEROXIDE AS RAW MATERIAL | Shanghai Hybrid-Chem Technologies (CN) | 2020-06-17 | — | — | EP | claimed |
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) | 2021-03-16 | — | — | US | disclosed |
| EP-3666755-A1 | ONLINE FULL CONTINUOUS FLOW PRODUCTION PROCESS FOR DIRECTLY PREPARING ORGANIC PEROXIDE WITH HYDROGEN PEROXIDE AS RAW MATERIAL | Shanghai Hybrid-Chem Technologies (CN) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172478-A1 | ONLINE CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF ORGANIC PEROXIDES USING HYDROGEN PEROXIDE AS RAW MATERIAL | SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) | 2020-06-04 | — | — | US | disclosed |
| EP-0513966-B1 | Bis-bibenzimidazole composition | ZENECA LTD (GB) | 1998-04-29 | — | — | EP | disclosed |
| US-5258524-A | Solvent extraction of zinc | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-11-02 | — | — | US | disclosed |
| EP-0196153-B1 | PROCESS FOR THE EXTRACTION OF METAL VALUES AND NOVEL METAL EXTRACTANTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-07-26 | — | — | EP | disclosed |
| US-4822880-A | 1,1'-SUBSTITUTED 2,2'-BIIMIDAZOLE OR BIBENZIMIDAZOLES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-04-18 | — | — | US | disclosed |
| US-4696801-A | Process for the extraction of metal values with bisimidazole metal extractants | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-09-29 | — | — | US | disclosed |
| EP-0196153-A2 | Process for the extraction of metal values and novel metal extractants | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-10-01 | — | — | EP | disclosed |
| US-4403056-A | POLYVINYL CHLORIDE PLASTICIZER | STAUFFER CHEMICAL COMPANY (US) | 1983-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | PPOX, HAO2, AOX1 | RARB 2501/4885NAAA 2425/4885KDM4C 3967/4885 |
| US-20200172478-A1 | ONLINE CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF ORGANIC PEROXIDES USING HYDROGEN PEROXIDE AS RAW MATERIAL | PPOX, HAO2, AOX1 | RARB 2501/4885NAAA 2425/4885KDM4C 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.